Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
40.37
-0.46 (-1.13%)
Nov 6, 2026, 3:00 PM CST

SHA:600211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,4102,3271,6481,8601,140764.41
Trading Asset Securities
371.011,123976.62515.34792.49537.87
Cash & Short-Term Investments
3,7813,4502,6252,3751,9321,302
Cash Growth
15.60%31.44%10.51%22.92%48.38%66.22%
Accounts Receivable
656.67917.49732.82856.71625.68632.32
Other Receivables
32.2717.4411.8511.8212.6312.83
Receivables
688.94934.93744.67868.52638.31645.15
Inventory
213.15181.27134.19111.4399.95137.32
Prepaid Expenses
-0.070.310.011.5-
Other Current Assets
63.3670.8965.9147.7740.0497.16
Total Current Assets
4,7474,6373,5703,4032,7122,182
Property, Plant & Equipment
622.49655.35669.85600.33551.38764.54
Long-Term Investments
380.92425.5132.94116.62129.75130.25
Goodwill
80.9684.018.888.888.888.88
Other Intangible Assets
262.93300.78184.09202.46416.48411.66
Long-Term Deferred Tax Assets
127.67132.52151.05115.4871.3467.16
Long-Term Deferred Charges
6.285.622.631.932.7947.69
Other Long-Term Assets
29.5726.327.99138.79206.96190.57
Total Assets
6,2576,2674,7474,5874,1003,803

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
69.4831.913.55.5114.3713.22
Accrued Expenses
63.16587.08377.65530.39412.7398.67
Short-Term Debt
1,223840.34272.17499.99486.1534.66
Current Portion of Leases
0.490.850.920.8812.13
Current Income Taxes Payable
-29.0325.545.3127.1322.13
Current Unearned Revenue
10.922.954.919.845.343.29
Other Current Liabilities
366.77147.9771.9292.5679.56135.56
Total Current Liabilities
1,7341,640766.571,1841,0261,110
Long-Term Debt
30.02-----
Long-Term Leases
0.280.150.31.131.141.86
Long-Term Unearned Revenue
26.4628.1127.3625.8527.5330.5
Long-Term Deferred Tax Liabilities
24.6625.4612.2914.0115.61
Other Long-Term Liabilities
445.24436.06----
Total Liabilities
2,2602,130795.231,2141,0691,158

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
322.32322.32322.32247.94247.94247.94
Additional Paid-In Capital
733.32752.21,1881,2631,2661,265
Retained Earnings
2,7972,6642,3301,7731,4551,169
Comprehensive Income & Other
30.8359.5177.5761.2142.98-51.42
Total Common Equity
3,7053,7983,9183,3453,0122,630
Minority Interest
291.91339.0534.2929.0319.0314.66
Shareholders' Equity
3,9974,1373,9523,3743,0312,645
Total Liabilities & Equity
6,2576,2674,7474,5874,1003,803

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,253841.34273.39501.99488.25538.65
Net Cash (Debt)
2,5282,6092,3511,8731,444763.63
Net Cash Growth
9.74%10.95%25.54%29.71%89.11%-1.22%
Net Cash Per Share
7.858.097.295.804.482.36
Filing Date Shares Outstanding
329.06322.32322.32322.32322.32322.32
Total Common Shares Outstanding
329.06322.32322.32322.32322.32322.32
Working Capital
3,0132,9972,8032,2181,6861,072
Book Value Per Share
11.2611.7812.1610.389.348.16
Tangible Book Value
3,3613,4143,7253,1332,5862,210
Tangible Book Value Per Share
10.2210.5911.569.728.026.86
Buildings
-535.52530.79462.4389.99439.89
Machinery
-309.36279.08446.34139.22159.08
Construction In Progress
-39.5365.0660.71153.6272.13